Bank of America’s GlucoTrack GCTK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
– Sell
-2
Closed -$108 – 6170
2025
Q4
$108 Buy
+2
New +$178 ﹤0.01% 6806
2025
Q3
– Sell
-273
Closed -$24.7K – 8029
2025
Q2
$24.5K Buy
+273
New +$36K ﹤0.01% 7009
2025
Q1
– Hold
0
– – – 8275
2024
Q4
– Hold
0
– – – 8078
2024
Q3
– Hold
0
– – – 7765

Other funds holding GCTK

Bank of America's GCTK Position: Q1 2026 in Review

Bank of America sold out of GlucoTrack (GCTK) in Q1 2026, closing a stake of 2 shares — an estimated $108 sold.

Bank of America first reported a position in GCTK in Q2 2025 and held it in 2 quarters. The position peaked at $24.5K in Q2 2025. 10 funds tracked by Wall St. Rank hold GCTK as of Q1 2026.

  • Bank of America reported no remaining GlucoTrack position as of Q1 2026 after selling out during the quarter.
  • Bank of America sold 2 GlucoTrack shares in Q1 2026, an estimated $108.
  • Bank of America first reported a position in GlucoTrack in Q2 2025 and held it in 2 quarters.
  • Bank of America's GlucoTrack position peaked at $24.5K in Q2 2025.
  • 10 funds tracked by Wall St. Rank held GlucoTrack as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.